REFERENCES
- National Academies of Sciences. Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health. Making Eye Health a Population Health Imperative: Vision for Tomorrow. Welp A, Woodbury RB, McCoy MA, Teutsch SM, eds. Washington (DC): National Academies Press (US); 2016.
- Varma R, Vajaranant TS, Burkemper B, et al. Visual impairment and blindness in adults in the United States: demographic and geographic variations from 2015 to 2050. JAMA Ophthalmol. 2016;134(7):802–809. doi:10.1001/jamaophthalmol.2016.1284.
- Kirtland KA, Saaddine JB, Geiss LS, et al. Geographic disparity of severe vision loss - United States, 2009-2013. MMWR Morb Mortal Wkly Rep. 2015;64(19):513–517.
- Zambelli-Weiner A, Friedman DS. Building a basis for action: enhancing public health surveillance of vision impairment and eye health in the United States. Am J Ophthalmol. 2012;154(6 Suppl):S8–22.e1. doi:10.1016/j.ajo.2012.06.006.
- US Census Bureau. How disability data are collected from the American community survey. 2021. Available at: https://www.census.gov/topics/health/disability/guidance/data-collection-acs.html [Accessed March 12, 2022].
- US Census Bureau. How the census bureau measures poverty. 2021. Available at: https://www.census.gov/topics/income-poverty/poverty/guidance/poverty-measures.html [Accessed March 12, 2022].
- US Census Bureau. When to use 1-year or 5-year estimates. 2021. Available at: https://www.census.gov/programs-surveys/acs/guidance/estimates.html [Accessed March 12, 2022].
- Anon. Rural-urban continuum codes. Available at: https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx [Accessed March 12, 2022].
- Flaxman AD, Wittenborn JS, Robalik T, et al. Prevalence of visual acuity loss or blindness in the US: a Bayesian Meta-analysis. JAMA Ophthalmol. 2021;139(7):717–723. doi:10.1001/jamaophthalmol.2021.0527.
- Congdon N, O’Colmain B, Klaver CCW, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–485.
- Chan T, Friedman DS, Bradley C, Massof R. Estimates of incidence and prevalence of visual impairment, Low Vision, and Blindness in the United States. JAMA Ophthalmol. 2018;136(1):12–19. doi:10.1001/jamaophthalmol.2017.4655.
- Nielsen M, D’Agostino D, Gregory P. Addressing rural health challenges head on. Mo Med. 2017;114:363–366.
- Rathi S, Tsui E, Mehta N, et al. The Current state of teleophthalmology in the United States. Ophthalmology. 2017;124(12):1729–1734. doi:10.1016/j.ophtha.2017.05.026.
- Liu Y, Zupan NJ, Swearingen R, et al. Identification of barriers, facilitators and system-based implementation strategies to increase teleophthalmology use for diabetic eye screening in a rural US primary care clinic: a qualitative study. BMJ Open. 2019;9(2):e022594. Available at. doi:10.1136/bmjopen-2018-022594.
- Fischer SH, Ray KN, Mehrotra A, Bloom EL, Uscher-Pines L. Prevalence and characteristics of telehealth utilization in the United States. JAMA Netw Open. 2020;3(10):e2022302. doi:10.1001/jamanetworkopen.2020.22302.
- Zhang X, Saaddine JB, Lee PP, et al. Eye care in the United States: do we deliver to high-risk people who can benefit most from it? Arch Ophthalmol. 2007;125(3):411–418. doi:10.1001/archopht.125.3.411.
- Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the rotterdam study. Arch Ophthalmol. 1998;116(5):653–658. doi:10.1001/archopht.116.5.653.
- Zetterberg M, Celojevic D. Gender and cataract – the role of estrogen. Curr Eye Res. 2015;40(2):176–190. doi:10.3109/02713683.2014.898774. Available at.
- Vajaranant TS, Nayak S, Wilensky JT, Joslin CE. Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol. 2010;21(2):91–99. doi:10.1097/ICU.0b013e3283360b7e.
- Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–412. doi:10.2147/OPTH.S5555.
- Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119–125. doi:10.1016/s1568-9972(03)00006-5. Available at.
- Sen HN, Davis J, Ucar D, et al. Gender disparities in ocular inflammatory disorders. Curr Eye Res. 2015;40(2):146–161. doi:10.3109/02713683.2014.932388.
- Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ. Sex differences in clinical characteristics of dry eye disease. Ocul Surf. 2018;16(2):242–248. doi:10.1016/j.jtos.2018.01.001.
- Borrelli M, Frings A, Geerling G, Finis D. Gender-specific differences in signs and symptoms of dry eye disease. Curr Eye Res. 2021;46(3):294–301. doi:10.1080/02713683.2020.1801758.
- Basch CE. Vision and the achievement gap among urban minority youth. J Sch Health. 2011;81(10):599–605. doi:10.1111/j.1746-1561.2011.00633.x.
- Birch EE, Kelly KR. Pediatric ophthalmology and childhood reading difficulties: amblyopia and slow reading. J Aapos. 2017;21(6):442–444. doi:10.1016/j.jaapos.2017.06.013.
- Flores G, Lin H, Walker C, et al. The health and healthcare impact of providing insurance coverage to uninsured children: a prospective observational study. BMC Public Health. 2017;17(1):553. doi:10.1186/s12889-017-4363-z.
- Reports CP Health insurance coverage in the United States: 2020. Available at: https://www.census.gov/content/dam/Census/library/publications/2021/demo/p60-274.pdf.
- Hamersma S, Kim M, Timpe B. The effect of parental medicaid expansions on children’s health insurance coverage. Contemp Econ Policy. 2019;37(2):297–311. doi:10.1111/coep.12392.
- Lipton BJ. Association between changes in parental medicaid vision coverage and child use of vision care. Acad Pediatr. 2021;21(1):101–108. doi:10.1016/j.acap.2020.10.007.